Sophrosyne Technologies, a semiconductor startup, has raised $2 million in a Seed funding round from Chennai-based Bluehill VC.
The funds will help the company move from prototype chips to full production, expand its engineering team, and begin early customer launches in India and abroad.
“By consolidating multiple sensing functions into one compact architecture, the company enables wearable devices to deliver richer and more continuous health insights with a smaller silicon footprint,” the startup said.
“Wearable health is entering a new phase where accuracy and continuous monitoring are becoming standard expectations,” said Sridhar Parthasarathi, managing partner at Bluehill VC. He added that Sophrosyne is solving practical problems for device makers, especially around power use and system complexity.
Manish Srivastava, cofounder and CEO of Sophrosyne, “We are moving toward production-grade silicon and early rollouts with OEMs. Bluehill’s semiconductor expertise will help us scale globally,” he said.
The startup recently received a $1.2 million grant from MeitY after clearing technical checks under the government’s semiconductor design program.
Sophrosyne Technologies, based in Bengaluru, was founded in 2024 by Manish Srivastava.
The startup is developing a biosensing system-on-chip (SoC) that can track ECG, PPG, breathing, temperature, and other signals in wearable devices while using very little power.
Read more- Hopr raises $3 million Seed round
